Back

Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Baiba Kokina

Riga Stradins University, Riga (Latvia)

6 More presentations in this session

Presentation thumbnail
Discussant - Expanding pharmacological and non-pharmacological options for coronary disease
Presentation thumbnail
The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials
Doctor S. Del Vecchio Ziotti (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Impact of nebivolol versus carvedilol on long-term clinical outcomes in STEMI patients treated with drug-eluting stents
Slides Video
Presentation thumbnail
Baseline characteristics, treatment and mortality among acute myocardial infarction patients with varying left ventricular ejection fractions according to the Estonian Myocardial Infarction Registry
Doctor J. Smirnova (Tartu, EE)
Abstract
Presentation thumbnail
Preliminary experience with comprehensive treatment in patients with rapidly progressive coronary artery disease (RP-CAD)
Doctor Y. Liu (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis
thumbnail
Congress Presentation
Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources